US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 25.200
- -0.280-1.10%
Close Nov 4 16:00 ET
- 25.250
- +0.050+0.20%
Post 16:55 ET
4.74BMarket Cap-9545P/E (TTM)
25.810High24.390Low1.26MVolume25.000Open25.480Pre Close31.73MTurnover0.99%Turnover RatioLossP/E (Static)188.03MShares44.32052wk High-4.34P/B3.21BFloat Cap21.62052wk Low--Dividend TTM127.53MShs Float73.500Historical High--Div YieldTTM5.57%Amplitude4.980Historical Low25.263Avg Price1Lot Size
BridgeBio Pharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 16.67%447.77M | 5.78%519.69M | -7.85%434.88M | -7.85%434.88M | -8.23%543.27M | -46.38%383.79M | -26.81%491.29M | -43.59%471.92M | -43.59%471.92M | -1.27%591.98M |
| -Cash and cash equivalents | 34.89%407.96M | 16.66%475.22M | -0.20%375.94M | -0.20%375.94M | 4.55%505.21M | -35.66%302.44M | 9.64%407.37M | -4.34%376.69M | -4.34%376.69M | 167.95%483.24M |
| -Short-term investments | -51.06%39.81M | -47.01%44.47M | -38.10%58.95M | -38.10%58.95M | -65.01%38.05M | -66.88%81.36M | -71.99%83.93M | -78.50%95.23M | -78.50%95.23M | -74.06%108.74M |
| Receivables | -92.34%660K | 2,088.40%235.49M | -89.75%1.75M | -89.75%1.75M | -78.97%5.17M | -62.25%8.61M | -2.02%10.76M | -13.52%17.08M | -13.52%17.08M | 200.80%24.58M |
| -Other receivables | -92.34%660K | 2,088.40%235.49M | -89.75%1.75M | -89.75%1.75M | -78.97%5.17M | -62.25%8.61M | -2.02%10.76M | -13.52%17.08M | -13.52%17.08M | 218.82%24.58M |
| Prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -19.63%25.66M |
| Restricted cash | 599.49%139.41M | -99.49%131K | -56.10%16.65M | -56.10%16.65M | --16.65M | --19.93M | --25.5M | 21,329.38%37.93M | 21,329.38%37.93M | ---- |
| Other current assets | 38.21%28.4M | 11.78%28.11M | 10.87%24.31M | 10.87%24.31M | --22.58M | --20.55M | --25.15M | --21.92M | --21.92M | ---- |
| Total current assets | 42.36%616.24M | 41.74%783.42M | -12.98%477.59M | -12.98%477.59M | -8.49%587.67M | -43.87%432.88M | -22.83%552.7M | -38.25%548.85M | -38.25%548.85M | 0.39%642.22M |
| Non current assets | ||||||||||
| Net PPE | -25.17%17.11M | -19.22%19.47M | -21.40%19.84M | -21.40%19.84M | -20.47%21.75M | -23.09%22.86M | -22.56%24.1M | -45.08%25.25M | -45.08%25.25M | -39.04%27.34M |
| -Gross PPE | -25.17%17.11M | -19.22%19.47M | -21.40%19.84M | -21.40%19.84M | -20.47%21.75M | -23.09%22.86M | -22.56%24.1M | -45.08%25.25M | -45.08%25.25M | -39.04%27.34M |
| Goodwill and other intangible assets | -8.69%25.12M | -8.51%25.72M | -8.33%26.32M | -8.33%26.32M | -8.16%26.92M | -8.00%27.52M | -7.75%28.11M | -36.10%28.71M | -36.10%28.71M | -36.56%29.31M |
| Investments and advances | --117.01M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non current assets | -7.34%18.9M | -0.22%20.72M | 11.87%22.63M | 11.87%22.63M | -37.48%18.68M | -34.87%20.4M | -41.21%20.77M | -38.77%20.22M | -38.77%20.22M | -9.63%29.87M |
| Total non current assets | 151.69%178.14M | -9.69%65.91M | -7.27%68.79M | -7.27%68.79M | -22.17%67.34M | -22.18%70.78M | -24.70%72.98M | -40.14%74.18M | -40.14%74.18M | -38.99%86.52M |
| Total assets | 57.72%794.38M | 35.75%849.33M | -12.30%546.38M | -12.30%546.38M | -10.12%655.01M | -41.59%503.66M | -23.05%625.68M | -38.48%623.04M | -38.48%623.04M | -6.75%728.74M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 367.89%18.13M | 16.00%4.73M | -7.81%10.66M | -7.81%10.66M | -55.98%4.47M | -55.94%3.87M | -59.67%4.08M | -2.74%11.56M | -2.74%11.56M | -15.60%10.16M |
| -accounts payable | 367.89%18.13M | 16.00%4.73M | -7.81%10.66M | -7.81%10.66M | -55.98%4.47M | -55.94%3.87M | -59.67%4.08M | -2.74%11.56M | -2.74%11.56M | -15.60%10.16M |
| Current accrued expenses | -0.16%67.46M | 35.62%85.85M | -1.78%65.6M | -1.78%65.6M | -21.34%57.13M | -23.44%67.57M | -13.92%63.3M | -17.76%66.78M | -17.76%66.78M | 26.91%72.63M |
| Current debt and capital lease obligation | 22.43%4.62M | 23.68%4.54M | 12.33%4.13M | 12.33%4.13M | 2.30%4.14M | -12.39%3.78M | -15.79%3.67M | -25.58%3.68M | -25.58%3.68M | -19.10%4.04M |
| -Current capital lease obligation | 22.43%4.62M | 23.68%4.54M | 12.33%4.13M | 12.33%4.13M | 2.30%4.14M | -12.39%3.78M | -15.79%3.67M | -25.58%3.68M | -25.58%3.68M | -19.10%4.04M |
| Current deferred liabilities | 143.12%15.1M | 109.09%13.96M | -25.26%6.1M | -25.26%6.1M | -12.32%6.59M | -13.63%6.21M | --6.68M | --8.16M | --8.16M | --7.52M |
| Current liabilities | 22.02%134.36M | 46.46%141.48M | 18.46%143.84M | 18.46%143.84M | -11.01%106.07M | -21.99%110.12M | -6.64%96.6M | -10.10%121.43M | -10.10%121.43M | 24.39%119.19M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -0.30%1.72B | -0.06%1.72B | 0.92%1.74B | 0.92%1.74B | 1.12%1.73B | 1.31%1.73B | 0.10%1.73B | -0.08%1.72B | -0.08%1.72B | 22.79%1.71B |
| -Long term debt | -0.08%1.72B | 0.15%1.72B | 1.12%1.73B | 1.12%1.73B | 1.32%1.72B | 1.52%1.72B | 0.31%1.71B | 0.22%1.71B | 0.22%1.71B | 23.51%1.7B |
| -Long term capital lease obligation | -35.33%7.06M | -30.30%8.3M | -26.83%8.98M | -26.83%8.98M | -24.52%9.81M | -23.54%10.92M | -23.17%11.9M | -29.57%12.27M | -29.57%12.27M | -30.42%13M |
| Non current deferred liabilities | --16.96M | --19.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non current liabilities | -96.36%485K | -96.60%595K | -64.87%9.36M | -64.87%9.36M | -58.25%11.79M | -53.46%13.33M | -34.77%17.5M | 20.73%26.64M | 20.73%26.64M | 2.35%28.23M |
| Total non current liabilities | -0.06%1.74B | 0.12%1.74B | -0.08%1.75B | -0.08%1.75B | 0.16%1.74B | 0.41%1.74B | -0.44%1.74B | 0.19%1.75B | 0.19%1.75B | 22.39%1.74B |
| Total liabilities | 1.25%1.88B | 2.55%1.89B | 1.12%1.89B | 1.12%1.89B | -0.56%1.85B | -1.28%1.85B | -0.78%1.84B | -0.55%1.87B | -0.55%1.87B | 22.52%1.86B |
| Shareholders'equity | ||||||||||
| Share capital | 15.48%194K | 15.57%193K | 15.29%181K | 15.29%181K | 15.38%180K | 9.09%168K | 8.44%167K | 1.95%157K | 1.95%157K | 1.96%156K |
| -common stock | 15.48%194K | 15.57%193K | 15.29%181K | 15.29%181K | 15.38%180K | 9.09%168K | 8.44%167K | 1.95%157K | 1.95%157K | 1.96%156K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -20.49%-2.67B | -26.16%-2.6B | -33.49%-2.56B | -33.49%-2.56B | -34.36%-2.39B | -34.82%-2.22B | -25.96%-2.06B | -33.49%-1.92B | -33.49%-1.92B | -38.05%-1.78B |
| Paid-in capital | 64.09%1.85B | 64.55%1.82B | 57.77%1.48B | 57.77%1.48B | 59.11%1.46B | 26.33%1.13B | 27.55%1.11B | 11.55%938.7M | 11.55%938.7M | 11.70%917.33M |
| Less: Treasury stock | 0.00%275M | 0.00%275M | 0.00%275M | 0.00%275M | 0.00%275M | 0.00%275M | 0.00%275M | 0.00%275M | 0.00%275M | 0.00%275M |
| Gains losses not affecting retained earnings | -106.35%-4K | 116.67%2K | 109.45%31K | 109.45%31K | 109.77%34K | 114.75%63K | 96.87%-12K | -148.48%-328K | -148.48%-328K | -1,931.58%-348K |
| Total stockholders'equity | 19.76%-1.09B | 14.37%-1.05B | -7.94%-1.35B | -7.94%-1.35B | -6.07%-1.21B | -32.81%-1.36B | -17.74%-1.23B | -44.14%-1.25B | -44.14%-1.25B | -53.14%-1.14B |
| Noncontrolling interests | -12.54%10.83M | 5.13%12.67M | 20.93%11.72M | 20.93%11.72M | 71.66%13.81M | 17.74%12.39M | 3,800.32%12.05M | 100.48%9.69M | 100.48%9.69M | 6.93%8.04M |
| Total equity | 19.82%-1.08B | 14.56%-1.04B | -7.84%-1.34B | -7.84%-1.34B | -5.61%-1.19B | -32.97%-1.35B | -16.62%-1.21B | -43.83%-1.24B | -43.83%-1.24B | -53.61%-1.13B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data